Ethyl Vanillin

Ethyl Vanillin

SCHEMBL2536111

C=CC.CCOc1cc(C=O)ccc1O

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.88
MEN1 O00255 7/20 0.60
KMT2A Q03164 7/20 0.60
TOP2A P11388 1/20 0.58
HPGD P15428 3/20 0.58
TRIM24 O15164 1/20 0.58
ALDH5A1 P51649 1/20 0.58
ABAT P80404 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
TRIM33 Q9UPN9 1/20 0.58
ALPI P09923 1/20 0.55
ALPG P10696 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
KDM4E B2RXH2 2/20 0.54
ABL1 P00519 1/20 0.54
ABCB1 P08183 1/20 0.54
BCR P11274 1/20 0.54
PIM1 P11309 2/20 0.51
PIM3 Q86V86 2/20 0.51
PIM2 Q9P1W9 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Vanillin SCHEMBL28237106 0.94 ALDH1A1 (0.78) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL28149909 0.94 ALDH1A1 (0.93) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL719058 0.94 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL30247 0.94 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL29351334 0.94 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL28208513 0.92 ALDH1A1 (0.97) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL5277489 0.92 ALDH1A1 (0.97) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL28027365 0.92 ALDH1A1 (0.97) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL30402049 0.92 ALDH1A1 (0.97) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL30449764 0.90 ALDH1A1 (0.93) ALDH1A1MEN1KMT2ATOP2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105555273-A Compositions to alleviate presystemic metabolism of opioids UNIV VIRGINIA COMMONWEALTH 2016-05-04 CN claimed
US-20160051536-A1 COMPOSITIONS TO ALLEVIATE PRESYSTEMIC METABOLISM OF OPIOIDS VIRGINIA COMMONWEALTH UNIVERSITY (US) 2016-02-25 US claimed
EP-2983668-A1 COMPOSITIONS TO ALLEVIATE PRESYSTEMIC METABOLISM OF OPIOIDS Virginia Commonwealth University (US) 2016-02-17 EP claimed
WO-2015051525-A1 SYNTHESIS OF ACETAL/KETAL RHODIA OPERATIONS (FR) 2015-04-16 WO claimed
WO-2014168925-A1 COMPOSITIONS TO ALLEVIATE PRESYSTEMIC METABOLISM OF OPIOIDS VIRGINIA COMMONWEALTH UNIVERSITY (US) 2014-10-16 WO claimed
CN-110897138-A Cheese type edible essence containing ethyl vanillin propyl diacetal 苏州禾田香料有限公司 2020-03-24 CN disclosed
CN-105555273-A Compositions to alleviate presystemic metabolism of opioids UNIV VIRGINIA COMMONWEALTH 2016-05-04 CN disclosed
US-20160051536-A1 COMPOSITIONS TO ALLEVIATE PRESYSTEMIC METABOLISM OF OPIOIDS VIRGINIA COMMONWEALTH UNIVERSITY (US) 2016-02-25 US disclosed
EP-2983668-A1 COMPOSITIONS TO ALLEVIATE PRESYSTEMIC METABOLISM OF OPIOIDS Virginia Commonwealth University (US) 2016-02-17 EP disclosed
WO-2015051525-A1 SYNTHESIS OF ACETAL/KETAL RHODIA OPERATIONS (FR) 2015-04-16 WO disclosed
WO-2014168925-A1 COMPOSITIONS TO ALLEVIATE PRESYSTEMIC METABOLISM OF OPIOIDS VIRGINIA COMMONWEALTH UNIVERSITY (US) 2014-10-16 WO disclosed
US-8350085-B2 Cocrystallization NEW FORM PHARMACEUTICALS INC. (US) 2013-01-08 US disclosed
US-8212079-B2 Cocrystallization APTUIT (WEST LAFAYETTE), LLC (US) 2012-07-03 US disclosed
US-20110257430-A1 NOVEL COCRYSTALLIZATION APTUIT (KANSAS CITY), LLC (US) 2011-10-20 US disclosed
US-20090281195-A1 NOVEL COCRYSTALLIZATION S.S.C.I., INC. (US) 2009-11-12 US disclosed
US-7452555-B2 Cocrystallization S.S.C.I., INC. (US) 2008-11-18 US disclosed
US-20070287194-A1 Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound S.S.C.I., INC 2007-12-13 US disclosed